Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Gross Profit: 2021-2025

Historic Gross Profit for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to $103.2 million.

  • Immunocore Holdings' Gross Profit rose 29.30% to $103.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $376.9 million, marking a year-over-year increase of 28.32%. This contributed to the annual value of $307.5 million for FY2024, which is 23.79% up from last year.
  • According to the latest figures from Q3 2025, Immunocore Holdings' Gross Profit is $103.2 million, which was up 6.45% from $96.9 million recorded in Q2 2025.
  • Immunocore Holdings' 5-year Gross Profit high stood at $103.2 million for Q3 2025, and its period low was $8.9 million during Q4 2021.
  • Over the past 3 years, Immunocore Holdings' median Gross Profit value was $73.7 million (recorded in 2024), while the average stood at $77.2 million.
  • Data for Immunocore Holdings' Gross Profit shows a peak YoY spiked of 32.44% (in 2025) over the last 5 years.
  • Quarterly analysis of 4 years shows Immunocore Holdings' Gross Profit stood at $8.9 million in 2021, then reached $70.0 million in 2023, then rose by 19.67% to $83.7 million in 2024, then rose by 29.30% to $103.2 million in 2025.
  • Its Gross Profit stands at $103.2 million for Q3 2025, versus $96.9 million for Q2 2025 and $93.0 million for Q1 2025.